Sovereign Health Article Spotlights Political Debate on Opioid Addiction Treatment Implant
Sovereign Health has released a new article focused on the ongoing debate about Probuphine, a subdermal implant for the treatment of opioid addiction. As noted in the piece, "Political debate leaves opioid implant hanging in the balance," Braeburn Pharmaceuticals – the creator of Probuphine – announced that it's still moving forward and investing $20 million to plant a research and development manufacturing site in Durham, North Carolina.
View full press release